Non-small-cell lung cancer

Area of Science:

• Oncology
• Pulmonology
• Cancer Research

Background:

• Non-small-cell lung cancer (NSCLC) is a leading cause of cancer mortality globally.
• Recent advancements in the last decade have significantly improved NSCLC management and patient prognosis.
• Key areas of improvement include screening, surgical and radiotherapeutic techniques, and systemic treatments.

Purpose of the Study:

• To review the recent improvements in the management of non-small-cell lung cancer.
• To highlight the impact of novel strategies on patient outcomes in both non-metastatic and metastatic NSCLC.
• To emphasize the future direction of individualized treatment concepts.

Main Methods:

• Review of recent literature and clinical advancements in NSCLC management.
• Analysis of the impact of systematic screening (low-dose CT) on early detection.
• Evaluation of novel surgical, radiotherapeutic, and systemic treatment options.

Main Results:

• Improved cure rates in non-metastatic NSCLC through perioperative strategies and adjuvant immunotherapy for locally advanced disease.
• Prolonged disease control and preserved quality of life in metastatic NSCLC with novel drug implementation.
• Significant progress in understanding NSCLC biology leading to innovative systemic therapies.

Conclusions:

• The prognosis for NSCLC patients has improved due to advancements in screening, treatment modalities, and biological understanding.
• Combination strategies and novel drugs offer enhanced outcomes for both early-stage and advanced NSCLC.
• Development of predictive clinical and genetic markers is crucial for future personalized NSCLC treatment.